Consortium partners
A pan-European public–private partnership uniting 42 partners across 17 countries to deliver evidence-based exit strategies for cardiovascular disease.
Independent expertise
Advisory board
The EXIT-CVD advisory board brings independent clinical, scientific, patient, and industry expertise to guide consortium priorities, study design, and real-world impact.
-
Prof. Anna Bergström
Clinical Cardiology
Karolinska Institutet, Sweden
-
Dr. Marco Ricci
Health Technology Assessment
European Society of Cardiology
-
Prof. Elena Vasileva
Patient Advocacy
European Heart Network
-
Dr. James Okafor
Digital Health & AI
Imperial College London, UK
-
Prof. Sophie Laurent
Regulatory Science
INSERM, France
-
Dr. Henrik Meier
Industry Innovation
MedTech Europe
More related content
Discover who drives the project and how work is organised across the consortium.